Complete Genomics to Announce New Product Launches at AGBT General Meeting

Logo PR Newswire
PR Newswire

SAN JOSE, Calif., Jan. 24, 2023 /PRNewswire/ -- Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. ("MGI"), today announced it plans to launch three new products at the Advances in Genome Biology and Technology (AGBT) General Meeting on February 6-9 in Hollywood, Florida. The Company will launch an ultra-high-speed sequencer with mid to low range throughput, an ultra-high throughput sequencer, and a novellibrary prep kit for long fragment sequencing.

"We are excited to unveil our new massively parallel next-generation sequencing products at this year's AGBT meeting. Over the years, our products have empowered countless customers and partners around the world in their scientific research and clinical applications. We look forward to rolling out these new product offerings with more power backed by our state-of-the-art technologies, to enhance sequencing capacities and accelerate breakthroughs in life science and healthcare, and to enable understanding and monitoring of our molecular health and early disease detection and prevention." said Rade Drmanac, PhD, Chief Scientific Officer.

Complete Genomics is advancing life science technology with an innovative product portfolio based on its highly efficient and accurate core technology known as DNBSEQ™. Complete Genomics offers quality genetic sequencers covering a wide range of applications from low,tomedium, and to ultra-high sequencing throughput. Complete Genomics multi-omics platforms include genetic sequencing (from sample and library prep kits to downstream bioinformatics systems), medical imaging, and laboratory automation.

AGBT is the preeminent genome science and technology conference bringing together heads of labs, institutions, businesses, financial analysts, and other high-level stakeholders to advance the field and drive game-changing innovation. Complete Genomics is looking forward to participating in this important event where significant scientific advances are announced and showcased, science and industry forge enduring partnerships, and significant investments and notable acquisitions are made.

Please plan to join us in the Complete Genomics Suite #318 to learn more about our DNBSEQ sequencing and laboratory automation platforms and see product demonstrations.

In addition, Complete Genomics will be hosting the following activities during AGBT:

  • Breakfast hall on Feb 7th from 7:30-9:00 a.m. Stop by and register for our raffles.
  • Cocktail party on Feb 7th from 5-7:15 p.m.
  • Suite talks on Feb 7-9th from 8-9 a.m. featuring product overviews and demonstrations.

About Complete Genomics

Complete Genomics Inc, a subsidiary of MGI Tech Co., Ltd., is a global life science company offering lab automation and a comprehensive high throughput sequencing product portfolio. Founded in 2006 and located in San Jose, California, Complete Genomics maintains a demo lab and full supply center with all of the reagents, lab automation equipment, and sequencers locally stored for customers. Complete Genomics released its first next-generation sequencing system, the DNBSEQ-G400C* platform in the US, in August 2022 and DNBSEQ T7* and DNBSEQ-T10x4* in January 2023. For all sequencer specifications, please visit the Complete Genomics website.

*Unless otherwise informed, StandardMPS and CoolMPS sequencing reagents, and sequencers for use with such reagents, are not available in Germany, Spain, UK, Sweden, Belgium, Italy, Finland, Czech Republic, Switzerland, Portugal, Austria, and Romania. Unless otherwise informed, StandardMPS sequencing reagents, and sequencers for use with such reagents are not available in Hong Kong.

Cision View original content:

SOURCE Complete Genomics

Logo PR Newswire
DUBLIN, Jan. 23, 2023 /PRNewswire/ -- The "Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Products...

Logo GlobeNewswire
SciencePress Release2023-01-24 12:00:00
BOCA RATON, Fla., Jan. 24, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (First Wave BioPharma or the Company), a clinical-stage...

Logo Nasdaq
Business / FinanceBy Rtt News2023-01-23 13:24:07
(RTTNews) - Agilent Technologies, Inc. (A) announced Monday an agreement with Quest Diagnostics (DGX), a diagnostic information services company, to enable...

Logo Benzinga
Business / FinanceBy Globe Newswire2023-01-23 13:01:00
Bionano Prep SP-G2 (SP-G2) kit offers higher gDNA quality, improved ease-of-use and increased DNA throughput Bionano Prep Direct Label and Stain-G2 (DLS-G2)...

Logo PR Newswire
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at...

Logo GlobeNewswire
SciencePress Release2023-01-23 21:05:00
SEATTLE, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Adaptive Biotechnologies) (Nasdaq: ADPT), a commercial stage biotechnology...

Logo PR Newswire
HealthPress Release2023-01-24 12:00:00
REHOVOT, Israel, Jan. 24, 2023 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics,...

Logo PR Newswire
HealthPress Release2023-01-24 11:30:00
BOSTON, Jan. 24, 2023 /PRNewswire/ -- NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multiomics, announced...

Logo GlobeNewswire
SciencePress Release2023-01-24 09:00:00
AVT02 as Simlandi is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure REYKJAVIK, Iceland and DUBAI, United Arab...

Logo PR Newswire
HealthPress Release2023-01-24 10:56:00
Two successful exits – Syndesi and BioPhero Four portfolio companies reported clinical data from first in class targets (Galecto, NMD Pharma, Heparegenix and...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 10:00:00
ATUM, a global specialist and industry leader in bioengineering solutions, today announced the signing of a full licensing agreement for the Leap-In...

Logo PR Newswire
TechnologyPress Release2023-01-23 22:30:00
(TSXV-PGV) TORONTO, Jan. 23, 2023 /CNW/ - Prodigy Ventures Inc. (TSXV: PGV) ("Prodigy" or the "Company") today announced that it has called a special meeting...

Logo GlobeNewswire
SciencePress Release2023-01-23 21:30:00
Achieved record sepsis product revenue and sepsis-driven T2Dx Instrument units in 2022 LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems,...

Logo GlobeNewswire
LONDON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Milltrust Ventures, the venture investment arm of Milltrust International, an award-winning investment organisation...

Logo NewsFileCorp
Press Release2023-01-24 11:52:00
Dieppe, New Brunswick--(Newsfile Corp. - January 24, 2023) - Colibri Resource Corporation (TSXV: CBI) ("Colibri" or the "Company") is pleased to report that...

Logo NewsFileCorp
Press Release2023-01-23 14:37:00
Calgary, Alberta--(Newsfile Corp. - January 23, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to...

Logo The Business Journals
Technology2023-01-23 19:47:07
Genetesis has added three new executives to its team as it nears a key FDA approval.

Logo NewsFileCorp
Press Release2023-01-23 14:09:00
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) (" GHG " or the " Company...

Logo GlobeNewswire
SciencePress Release2023-01-23 13:00:00
Mr. Smith joins IO Biotech bringing over two decades of legal and compliance experience in the life science industries NEW YORK, Jan. 23, 2023 (GLOBE...

Logo GlobeNewswire
SciencePress Release2023-01-23 14:22:00
NEW HAVEN, Conn., Jan. 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the Company or Bioasis ), a multi-asset rare and...